Latest Period
Q1 2026
Security Snapshot
CG Oncology, Inc. - COMMON STOCK (CGON) Institutional Ownership
CUSIP: 156944100
13F Institutional Holders and Ownership History from Q1 2024 to Q1 2026
Institutions Reporting
233
Shares (Excl. Options)
88,132,565
Price
$67.68
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / COMMON STOCK
- Symbol
- CGON on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 88,132,565
- Total 13F value
- $5,928,392,162
- Portfolio coverage rank
- 0.01%
- Share change
- +5,343,444
- Value change
- +$431,703,789
- Number of holders
- 233
- Shares outstanding
- 84,004,863
- SEC-reported price per share
- $69.32
- Insider filing price
- $69.32
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CGON - CG Oncology, Inc. - COMMON STOCK is tracked under CUSIP 156944100.
- 233 institutions reported positions in Q1 2026.
- 10 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 194 to 233 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $3,430,450,689 to $5,928,392,162.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 233 institutions filings for Q1 2026.
Security key
156944100
Latest holder period
Q1 2026
13F holders
233
13D/G owners
10
CIK / CUSIP context first
Open Q1 2026 holders
CGON full holder history
CG Oncology, Inc. SEC filings
CG Oncology, Inc. company facts
CG Oncology, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 156944100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
10
Security
CGON
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 8.3% | $472,871,502 | 6,984,808 | RTW Investments, LP | 31 Mar 2026 | |||
| T. Rowe Price Investment Management, Inc. | 8% | $454,970,335 | 6,720,389 | T. Rowe Price Investment Management, Inc. | 31 Mar 2026 | |||
| Decheng Capital Global Life Sciences Fund IV, L.P. | 8.4% | $178,215,582 | 6,371,669 | Xiangmin Cui | 31 Dec 2024 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 7.2% | $222,054,738 | 5,512,779 | Wellington Management Group LLP | 30 Sep 2025 | |||
| Longitude Capital Partners IV, LLC | 6% | $121,032,477 | 4,662,268 | Patrick G. Enright | 11 Sep 2025 | |||
| Unique Diamond Investments Ltd | 5.5% | $117,791,208 | 4,211,341 | SONG, Hong Fang | 31 Dec 2024 | |||
| FMR LLC | 5.1% | $100,262,786 | 3,856,261 | FMR LLC | 30 Jun 2025 | |||
| TCG Crossover GP I, LLC | 4.8% | $102,655,662 | 3,670,206 | TCG Crossover GP I, LLC | 31 Mar 2025 | |||
| Seven Fleet Capital Management LP | 2% | $62,145,313 | 1,542,833 | Brian Liu | 06 Oct 2025 | |||
| Seven Fleet Partners LP | 1.9% | $39,333,320 | 1,515,151 | Seven Fleet Partners LP | 11 Sep 2025 |
As of 31 Mar 2026, 233 institutional investors reported holding 88,132,565 shares of CG Oncology, Inc. - COMMON STOCK (CGON). This represents 105% of the company’s total 84,004,863 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
82%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| RTW INVESTMENTS, LP | 8.3% | 6,984,808 | +247% | 4.7% | $472,731,805 |
| T. Rowe Price Investment Management, Inc. | 8% | 6,720,389 | +1490% | 0.31% | $454,836,000 |
| Decheng Capital LLC | 7.6% | 6,371,669 | 0% | 65% | $431,234,558 |
| WELLINGTON MANAGEMENT GROUP LLP | 6.4% | 5,371,232 | -10% | 0.07% | $363,524,981 |
| BlackRock, Inc. | 6% | 5,064,180 | +4.6% | 0.01% | $342,743,702 |
| FMR LLC | 4.5% | 3,764,844 | -12% | 0.01% | $254,804,642 |
| TCG Crossover Management, LLC | 4.4% | 3,670,206 | 0% | 7.1% | $248,399,542 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.3% | 3,652,980 | +6.1% | 0.03% | $247,234,000 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 3.7% | 3,095,098 | 0% | 0.01% | $209,476,233 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.6% | 3,033,625 | 0% | 0.01% | $205,315,740 |
| STATE STREET CORP | 3.2% | 2,647,054 | -12% | 0.01% | $179,152,615 |
| Foresite Capital Management VI LLC | 2.6% | 2,221,474 | 0% | 33% | $150,349,360 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,596,864 | +5.6% | 0.01% | $108,101,410 |
| FRANKLIN RESOURCES INC | 1.8% | 1,507,005 | -3.5% | 0.02% | $101,994,129 |
| BANK OF AMERICA CORP /DE/ | 1.7% | 1,449,364 | +22% | 0.01% | $98,092,955 |
| DV Trading LLC | 1.7% | 1,439,393 | 0% | 8.8% | $97,418,118 |
| UBS Group AG | 1.6% | 1,311,978 | -32% | 0.02% | $88,794,671 |
| ALLIANCEBERNSTEIN L.P. | 1.5% | 1,290,087 | -20% | 0.02% | $53,564,412 |
| Avidity Partners Management LP | 1.5% | 1,288,948 | -12% | 17% | $87,236,001 |
| GOLDMAN SACHS GROUP INC | 1.4% | 1,159,239 | -12% | 0.01% | $78,457,296 |
| ACORN CAPITAL ADVISORS, LLC | 1.3% | 1,130,501 | -0.09% | 22% | $76,579,958 |
| EcoR1 Capital, LLC | 1.3% | 1,102,000 | +43% | 3.2% | $74,583,360 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1.3% | 1,064,966 | -2.4% | 0.01% | $72,076,900 |
| Foresite Capital Management V, LLC | 1.2% | 1,004,050 | 0% | 25% | $67,954,104 |
| Driehaus Capital Management LLC | 1.2% | 999,623 | 0.5% | $67,654,485 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Latest
Q1 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 88,132,565 | $5,928,392,162 | +$431,703,789 | $67.68 | 233 |
| 2025 Q4 | 82,634,318 | $3,430,450,689 | +$57,920,734 | $41.52 | 194 |
| 2025 Q3 | 77,648,888 | $3,127,517,509 | +$92,134,469 | $40.28 | 175 |
| 2025 Q2 | 75,914,566 | $1,973,784,426 | +$139,061,983 | $26.00 | 161 |
| 2025 Q1 | 70,762,639 | $1,735,652,621 | +$98,334,837 | $24.49 | 141 |
| 2024 Q4 | 66,057,386 | $1,894,540,823 | +$282,964,154 | $28.68 | 137 |
| 2024 Q3 | 52,183,069 | $1,962,909,867 | +$277,213,171 | $37.73 | 120 |
| 2024 Q2 | 43,274,514 | $1,366,161,770 | +$105,145,067 | $31.57 | 109 |
| 2024 Q1 | 38,771,794 | $1,702,050,758 | +$1,700,470,138 | $43.90 | 96 |